Search public Form 5500 filings

Filters & tools • active

Investigation panel

2 results

planAsklepios Biopharmaceuticals, Inc. 401(K) PlanFinancial statementProvider compensation2023 filing
$22Mreported assets (EOY)
Sponsor: Asklepios Biopharmaceutical, Inc.EIN: 20-0267834Plan: 001Participants: 342Assets: $22,014,629Net assets: $22MAssets / participant: $64.4KLocation: Research Triangle Pk, NCLatest: 2023
View financial statement →
planRecipharm Laboratories, Inc. 401(K) PlanFinancial statementProvider compensation2023 filing
$15Mreported assets (EOY)
Sponsor: Recipharm Laboratories, Inc.EIN: 56-2041552Plan: 001Participants: 345Assets: $15,037,768Net assets: $15MAssets / participant: $43.6KLocation: Research Triangle Pk, NCLatest: 2023
View financial statement →